Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-28-18 | Dec-29-17 | Dec-30-16 | Jan-01-16 | Jan-02-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Non-Medical | 38.5 | 35.5 | 58.4 | 53.0 | 57.0 | 41.7 | 59.4 | 81.8 |
Medical | 1,182.6 | 1,038.0 | 1,199.7 | 1,162.0 | 120.0 | 109.6 | 741.0 | 216.3 |
Other | | | | | 959.1 | 924.3 | | 389.7 |
Total revenues | 1,221.1 | 1,073.4 | 1,258.1 | 1,215.0 | 1,136.1 | 1,075.5 | 800.4 | 687.8 |
Revenue growth [+] | 13.8% | -14.7% | 3.5% | 6.9% | 5.6% | 34.4% | 16.4% | 3.6% |
Non-Medical | 8.4% | -39.3% | 10.3% | -7.0% | 36.7% | -29.9% | -27.3% | |
Medical | 13.9% | -13.5% | 3.2% | 868.3% | 9.5% | -85.2% | 242.5% | -42.6% |
Cost of goods sold | 884.1 | 787.7 | 903.1 | 852.3 | 782.1 | 737.8 | 565.3 | 456.4 |
Gross profit | 337.0 | 285.7 | 355.0 | 362.7 | 354.0 | 337.7 | 235.1 | 231.4 |
Gross margin | 27.6% | 26.6% | 28.2% | 29.8% | 31.2% | 31.4% | 29.4% | 33.6% |
Selling, general and administrative | 141.4 | 109.0 | 138.7 | 142.4 | 143.1 | 136.4 | 102.5 | 90.6 |
Research and development | 52.0 | 48.5 | 46.5 | 48.6 | 48.9 | 47.9 | 53.0 | 49.8 |
Other operating expenses | 7.9 | 7.6 | 12.2 | 16.1 | 36.4 | 60.4 | 66.5 | 15.3 |
EBITDA [+] | 217.1 | 199.9 | 235.5 | 244.5 | 228.4 | 183.4 | 57.8 | 112.9 |
EBITDA growth | 8.6% | -15.1% | -3.7% | 7.0% | 24.5% | 217.5% | -48.8% | 16.0% |
EBITDA margin | 17.8% | 18.6% | 18.7% | 20.1% | 20.1% | 17.1% | 7.2% | 16.4% |
Depreciation | 39.8 | 38.2 | 37.8 | 47.5 | 59.7 | 55.1 | 27.1 | 23.3 |
EBITA | 177.3 | 161.7 | 197.7 | 197.0 | 168.8 | 128.4 | 30.6 | 89.5 |
EBITA margin | 14.5% | 15.1% | 15.7% | 16.2% | 14.9% | 11.9% | 3.8% | 13.0% |
Amortization of intangibles | 41.6 | 41.1 | 40.1 | 41.5 | 43.1 | 35.5 | 17.5 | 13.9 |
EBIT [+] | 135.7 | 120.6 | 157.6 | 155.6 | 125.6 | 92.9 | 13.1 | 75.7 |
EBIT growth | 12.5% | -23.5% | 1.3% | 23.8% | 35.2% | 606.9% | -82.6% | 23.3% |
EBIT margin | 11.1% | 11.2% | 12.5% | 12.8% | 11.1% | 8.6% | 1.6% | 11.0% |
Interest expense | 31.6 | 38.2 | 52.5 | 99.3 | 64.0 | 68.3 | 33.5 | 4.3 |
Interest expense | 31.6 | 38.2 | 52.5 | 99.3 | 64.0 | 68.3 | 33.5 | 4.3 |
Other income (expense), net [+] | -3.0 | 3.8 | 0.1 | 4.9 | -12.4 | 3.6 | 4.7 | 5.2 |
Other | 0.1 | -1.5 | 0.6 | -0.8 | -10.9 | 4.4 | 1.3 | 0.8 |
Pre-tax income | 101.1 | 86.2 | 105.2 | 61.1 | 49.3 | 28.2 | -15.7 | 76.6 |
Income taxes | 8.0 | 8.9 | 14.0 | 14.1 | -37.8 | 3.3 | -8.1 | 21.1 |
Tax rate | 8.0% | 10.4% | 13.3% | 23.0% | | 11.7% | 51.6% | 27.6% |
Earnings from continuing ops | 93.0 | 77.3 | 91.2 | 47.0 | 87.1 | 24.9 | -7.6 | 55.5 |
Earnings from discontinued ops | 0.0 | | 0.0 | 0.0 | 0.0 | | | |
Net income | 93.0 | 77.3 | 91.2 | 47.0 | 87.1 | 24.9 | -7.6 | 55.5 |
Net margin | 7.6% | 7.2% | 7.3% | 3.9% | 7.7% | 2.3% | -0.9% | 8.1% |
|
Basic EPS [+] | $2.82 | $2.35 | $2.80 | $1.46 | $2.77 | $0.81 | ($0.29) | $2.23 |
Growth | 19.9% | -15.9% | 91.0% | -47.2% | 243.1% | -380.6% | -112.9% | 47.8% |
Diluted EPS [+] | $2.80 | $2.33 | $2.76 | $1.44 | $2.72 | $0.80 | ($0.29) | $2.14 |
Growth | 19.9% | -15.5% | 91.4% | -46.9% | 238.2% | -378.8% | -113.5% | 49.1% |
|
Shares outstanding (basic) [+] | 33.0 | 32.8 | 32.6 | 32.1 | 31.4 | 30.8 | 26.4 | 24.8 |
Growth | 0.5% | 0.7% | 1.5% | 2.3% | 2.0% | 16.7% | 6.2% | 3.5% |
Shares outstanding (diluted) [+] | 33.3 | 33.1 | 33.0 | 32.6 | 32.1 | 31.0 | 26.4 | 26.0 |
Growth | 0.4% | 0.2% | 1.4% | 1.7% | 3.5% | 17.5% | 1.5% | 2.6% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|